Gunnar F. Kaufmann, Chief Scientific Officer at Oncternal Therapeutics, Inc. (ONCT), bought 28,000 shares at $0.36 ($10K) on 2023-06-14, disclosed to the SEC on 2023-06-14.
Open-market purchase of $10k ONCT by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.35 | 25,000 | $9K | 89.0% |
| 2 | $0.36 | 3,000 | $1K | 11.0% |
| Total | $0.35 avg | 28,000 | $10K | 100% |